The expectant mother underwent a nuchal translucency (NT) test, a crucial step in the diagnostic process for Down syndrome. NT measurements are derived from ultrasound scans and maternal blood samples, offering valuable insights into the fetus’s genetic condition. These measurements, however, were far from definitive, as they were accompanied by a level of uncertainty inherent to the procedure.
